|
XRCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.197700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.645910E-02 |
| Normal-vs-Stage2 |
4.065800E-02 |
| Normal-vs-Stage3 |
2.317800E-02 |
| Normal-vs-Stage4 |
9.805600E-01 |
| Stage1-vs-Stage2 |
7.688600E-01 |
| Stage1-vs-Stage3 |
3.261000E-01 |
| Stage1-vs-Stage4 |
2.831200E-01 |
| Stage2-vs-Stage3 |
6.253400E-01 |
| Stage2-vs-Stage4 |
2.564800E-01 |
| Stage3-vs-Stage4 |
1.775240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.183100E-04 |
| Normal-vs-AfricanAmerican |
3.757700E-02 |
| Normal-vs-Asian |
7.288800E-01 |
| Caucasian-vs-AfricanAmerican |
5.374600E-01 |
| Caucasian-vs-Asian |
5.054600E-01 |
| AfricanAmerican-vs-Asian |
6.758400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.004000E-03 |
| Normal-vs-Female |
2.181400E-04 |
| Male-vs-Female |
4.428400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.295800E-02 |
| Normal-vs-Extreme_Weight |
3.520000E-02 |
| Normal-vs-Obese |
1.581510E-04 |
| Normal-vs-Extreme_Obese |
8.984600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.593600E-01 |
| Normal_Weight-vs-Obese |
1.682200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.961800E-01 |
| Extreme_Weight-vs-Obese |
2.332000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.643400E-01 |
| Obese-vs-Extreme_Obese |
7.994300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.990450E-01 |
| Normal-vs-Age(41-60Yrs) |
2.644300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.525800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.148640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.061200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.482000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.309800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.417700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.238600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.175400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.023500E-04 |
| Normal-VS-Type2 PRCC |
1.373360E-01 |
| Normal-VS-KIRP CIMP |
6.296600E-01 |
| Normal-VS-Unclassified PRCC |
1.241940E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.414200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.398000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.803600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.893620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.033180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.616400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.665440E-01 |
| Normal-vs-N1 |
3.350100E-02 |
| Normal-vs-N2 |
1.575380E-01 |
| N0-vs-N1 |
1.534410E-01 |
| N0-vs-N2 |
5.858600E-01 |
| N1-vs-N2 |
8.713200E-01 |
|
|
